Additional file 3 of Combined PD-1/PD-L1 and tumor-infiltrating immune cells redefined a unique molecular subtype of high-grade serous ovarian carcinoma

Additional file 3: Table S1: Clinical data for sample id, overall survival time, survival state, and the average expression of PD-1/PD-L1 in GSE53963, GSE32062, GSE135820, and TCGA-OV databases. PD-1, programmed death-1; PD-L1, programmed death ligand 1; TCGA, The Cancer General Atlas

附加文件3：表S1：包含样本ID、总生存期、生存状态，以及GSE53963、GSE32062、GSE135820与TCGA-OV数据库中程序性死亡受体1（programmed death-1）/程序性死亡配体1（programmed death ligand 1）的平均表达量的临床数据。其中，PD-1即程序性死亡受体1，PD-L1即程序性死亡配体1，TCGA即癌症基因组图谱（The Cancer General Atlas）。